PlainRecalls
FDA Drug Moderate Class II Terminated

Morphine 50 mg in 0.9% Sodium Chloride 5 mL PCA, 50 mL Cartridge, Concentration: 1 mg/mL, This is a compounded injectable drug; Rx only; Hospital/office use only. SSM St. Clare Outsourcing Facility, Fenton, MO. --- NDC: 88887-6795-01

Reported: January 3, 2018 Initiated: August 10, 2017 #D-0140-2018

Product Description

Morphine 50 mg in 0.9% Sodium Chloride 5 mL PCA, 50 mL Cartridge, Concentration: 1 mg/mL, This is a compounded injectable drug; Rx only; Hospital/office use only. SSM St. Clare Outsourcing Facility, Fenton, MO. --- NDC: 88887-6795-01

Reason for Recall

Lack of sterility assurance: Microbial growth detected during a routine simulation of the manufacturing process. No batches of distributed product have been identified as actually containing microorganisms.

Details

Units Affected
N/A
Distribution
SSM Health entities in the state of MO only
Location
Fenton, MO

Frequently Asked Questions

What product was recalled?
Morphine 50 mg in 0.9% Sodium Chloride 5 mL PCA, 50 mL Cartridge, Concentration: 1 mg/mL, This is a compounded injectable drug; Rx only; Hospital/office use only. SSM St. Clare Outsourcing Facility, Fenton, MO. --- NDC: 88887-6795-01. Recalled by SSM Health Care St. Louis DBA SSM St. Clare Health Center. Units affected: N/A.
Why was this product recalled?
Lack of sterility assurance: Microbial growth detected during a routine simulation of the manufacturing process. No batches of distributed product have been identified as actually containing microorganisms.
Which agency issued this recall?
This recall was issued by the FDA Drug on January 3, 2018. Severity: Moderate. Recall number: D-0140-2018.